Click below to listen now.
“This should be a wake-up call.”
After 16 weeks, the COMBINE study showed overall positive outcomes for study participants.
zoranm/Getty Images
It works by causing a severe adverse reaction when someone taking the medication consumes alcohol.
Most people who take it will vomit after a drink of alcohol.
This, in turn, is thought to create a deterrent to drinking.
Disulfiram was first developed in the 1920s for use in manufacturing processes.
The alcohol-aversive effects of Antabuse were first recorded in the 1930s.
Workers in the vulcanized rubber industry who were exposed to tetraethylthiuram disulfide became ill after drinking alcohol.
The researchers began a new set of studies on using disulfiram to treat alcohol dependence.
Shortly thereafter, the FDA approved disulfiram to treat alcoholism.
It was first manufactured by Wyeth-Ayerst Laboratories under the brand name Antabuse.
Naltrexone
Naltrexone is sold under the brand names Revia and Depade.
An extended-release, monthly injectable form of naltrexone is marketed under thetrade name Vivitrol.
Naltrexone was first developed in 1963 to treat addiction to opioids.
At the time, it was marketed by DuPont under the brand name Trexan.
In the 1980s, animal studies discovered that naltrexone also reduced alcohol consumption.
Human clinical trials followed in the late 80s and early 90s.
These showed that when combined with psychosocial therapy, naltrexone couldreduce alcohol cravingsand decrease relapse rates in alcoholics.
The FDA approved the use of naltrexone to treat alcohol use disorders in 1994.
DuPont then renamed the drug Revia.
In 1982, the French company Laboratoires Meram developed acamprosate for the treatment of alcohol dependence.
It was first marketed under the name Aotal.
For more than 20 years, acamprosate was widely used throughout Europe for treating people with alcohol use disorders.
It was not approved for use in the U.S. until July 2004.
Campral did not perform better than the placebo or dummy pill.
This finding stumped researchers since previous studies performed in Europe using Campral had yielded positive treatment outcomes.
Dr. Sinclair’s research has been published in the peer-reviewed journalsAlcohol and Alcoholismand theJournal of Clinical Psychopharmacology.
The change in behavior only appears over time.
With the Sinclair Method, Revia or Vivitrol is taken one hour before drinking alcohol.
Revia and Vivitrol block the feel-good endorphins.
It is believed that the main reason the Sinclair Method has not caught on in the U.S. is two-fold.
For more mental health resources, see ourNational Helpline Database.
Substance Abuse and Mental Health Services Administration.MAT Medications, Counseling, and Related Conditions.
2006;295(17):2003-17. doi:10.1001/jama.295.17.2003
Center for Substance Abuse Treatment.Incorporating Alcohol Pharmacotherapies into Medical Practice.
Substance Abuse and Mental Health Services Administration (US); 2009.
Winslow BT, Onysko M, Hebert M.Medications for alcohol use disorder.Am Fam Physician.
2016;93(6):457-465.
2001;36(1):2-10. doi:10.1093/alcalc/36.1.2
